Advertisement
Screener

MELINTA THERAPEUTICS, INC. /NEW/ Stock Split Ratio

MELINTA THERAPEUTICS, INC. /NEW/ Stock Split Ratio

MELINTA THERAPEUTICS, INC. /NEW/ had Stock Split Ratio of 20.00% as of 2019-02-22, per its 10-Q filed 2019-11-12.

Discontinued › Notes › Equity › Stockholders' Equity Note

us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2019-11-12

  • 2019-02-22: Stockholders' Equity Note, Stock Split, Conversion Ratio 20.00%.
  • 2018-02-22: Stockholders' Equity Note, Stock Split, Conversion Ratio 20.00%.
  • 2012-01-29: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 10.53%.
Period endStockholders' Equity Note, Stock Split, Conversion RatioStockholders' Equity Note, Stock Split, Conversion Ratio 1 month
2019-02-2220.00%
10-Q · filed 2019-11-12
2018-02-2220.00%
10-Q · filed 2019-11-12
2012-01-2910.53%
10-K · filed 2014-02-28